Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Says Places 10 NanoChip Sytems in Third Quarter

NEW YORK, Oct. 3 – Microarray technology developer Nanogen said Wednesday that it had sold seven of its NanoChip Molecular Biology Workstations during the quarter and placed another three through non-title transfer agreements to development site partners.

Nanogen said that it has placed 40 of its SNP scoring workstations to unnamed customers and collaborators.

Howard Birndorf, Nanogen’s founder and executive chairman, said that the company decided to make the announcement in light of the current economic downturn.

“I'm pleased to report that our title transfer transactions recorded as product revenue more than tripled over the last quarter, keeping us on track to meet our year-end placement goals and revenue forecasts," Birndorf said in a statement.

Nanogen’s microarray technology uses a matrix of 100 charged pads to immobilize strands of DNA to perform assays. It is designed to investigate SNPs, short tandem repeats, insertions, and deletions. 

On Tuesday, Nanogen competitor Sequenom announced that it had sold 10 of its MassArray gene analysis systems to a variety of companies and institutions during the third quarter. Sequenom said it has sold 48 systems to date.


The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.